Autoantibodies in polymyositis and dermatomyositis (Q38099556)

28 August 2017

Autoantibodies in polymyositis and dermatomyositis (English)

1 reference

28 August 2017

0 references

0 references

1 reference

Andrea Doria

7

0 references

Leonardo Punzi

object named as

Leonardo Punzi

6

0 references

author name string

Anna Ghirardello

1

1 reference

28 August 2017

Nicola Bassi

2

1 reference

28 August 2017

Lavinia Palma

3

1 reference

28 August 2017

Elisabetta Borella

4

1 reference

28 August 2017

Marta Domeneghetti

5

1 reference

28 August 2017

1 June 2013

1 reference

Current Rheumatology Reports

28 August 2017

1 reference

28 August 2017

15

1 reference

28 August 2017

6

1 reference

28 August 2017

335

1 reference

https://scigraph.springernature.com/pub.10.1007/s11926-013-0335-1

28 August 2017

0 references

cites work

Polymyositis and dermatomyositis (first of two parts)

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0335-1

Polymyositis and dermatomyositis (second of two parts)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0335-1

Polymyositis and dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0335-1

Review: An update on inflammatory and autoimmune myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0335-1

An unusual association: anti-Jo1 and anti-SRP antibodies in the serum of a patient with polymyositis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0335-1

High frequencies and co-existing of myositis-specific autoantibodies in patients with idiopathic inflammatory myopathies overlapped to rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0335-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0335-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0335-1

Clinical characteristics of patients with myositis and autoantibodies to different fragments of the Mi-2 beta antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0335-1

Autoantibody profiles in the sera of European patients with myositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0335-1

Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0335-1

Cutting edge issues in polymyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0335-1

The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0335-1

Novel autoantibodies and clinical phenotypes in adult and juvenile myositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0335-1

Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0335-1

Newly identified autoantibodies: relationship to idiopathic inflammatory myopathy subsets and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0335-1

Case records of the Massachusetts General Hospital. Case 37-2012. A 21-year-old man with fevers, arthralgias, and pulmonary infiltrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0335-1

Clinical implications of autoantibody screening in patients with autoimmune myositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0335-1

Clinical manifestations of anti-synthetase syndrome positive for anti-alanyl-tRNA synthetase (anti-PL12) antibodies: a retrospective study of 17 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0335-1

Interstitial lung disease and idiopathic inflammatory myopathies: progress and pitfalls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0335-1

Anti-PL-7 (anti-threonyl-tRNA synthetase) antisynthetase syndrome: clinical manifestations in a series of patients from a European multicenter study (EUMYONET) and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0335-1

Differences in idiopathic inflammatory myopathy phenotypes and genotypes between Mesoamerican Mestizos and North American Caucasians: ethnogeographic influences in the genetics and clinical expression of myositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0335-1

Clinical correlations with dermatomyositis-specific autoantibodies in adult Japanese patients with dermatomyositis: a multicenter cross-sectional study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0335-1

Ultraviolet radiation intensity predicts the relative distribution of dermatomyositis and anti-Mi-2 autoantibodies in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0335-1

Diagnostic performance and validation of autoantibody testing in myositis by a commercial line blot assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0335-1

The human Mi-2/NuRD complex and gene regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0335-1

The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0335-1

Human autoantibodies against the 54 kDa protein of the signal recognition particle block function at multiple stages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0335-1

Poor response of anti-SRP-positive idiopathic immune myositis to B-cell depletion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0335-1

Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0335-1

RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: Association with rapidly progressive interstitial lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0335-1

The RIG-I-like receptor IFIH1/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0335-1

Recognition of viral nucleic acids in innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0335-1

Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0335-1

Usefulness of anti-p155 autoantibody for diagnosing cancer-associated dermatomyositis: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0335-1

Malignancy and myositis: novel autoantibodies and new insights.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0335-1

Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0335-1

Dynamic regulation of p53 subnuclear localization and senescence by MORC3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0335-1

Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0335-1

Anti-MJ/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0335-1

Identification of a novel autoantibody directed against small ubiquitin-like modifier activating enzyme in dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0335-1

Clinical and human leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK Caucasian adult-onset myositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0335-1

Anti-SAE antibodies in autoimmune myositis: identification by unlabelled protein immunoprecipitation in an Italian patient cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0335-1

A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0335-1

Rarity of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies in statin users, including those with self-limited musculoskeletal side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0335-1

Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0335-1

Commercial blot assays in the diagnosis of systemic rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0335-1

Use of a commercial line blot assay as a screening test for autoantibodies in inflammatory myopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0335-1

Correlation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0335-1

Antibody levels correlate with creatine kinase levels and strength in anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0335-1

Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0335-1

Expression of the dermatomyositis autoantigen Mi-2 in regenerating muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0335-1

21 January 2018

Myositis autoantibodies

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0335-1

Polymyositis, dermatomyositis and malignancy: a further intriguing link

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0335-1

Cell stress response in skeletal muscle myofibers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0335-1

Myofiber stress-response in myositis: parallel investigations on patients and experimental animal models of muscle regeneration and systemic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0335-1

Clinical utility of anti-signal recognition particle antibody in the differential diagnosis of myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0335-1

A novel autoantibody to a 155-kd protein is associated with dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0335-1

Interstitial lung disease associated with anti-PM/Scl or anti-aminoacyl-tRNA synthetase autoantibodies: a similar condition?

21 January 2018

1 reference

12 December 2020

Anti-Jo-1 antibody levels correlate with disease activity in idiopathic inflammatory myopathy

1 reference

12 December 2020

Myositis-specific anti-155/140 autoantibodies target transcription intermediary factor 1 family proteins

1 reference

12 December 2020

Detection of antisynthetase syndrome in patients with idiopathic interstitial pneumonias

1 reference

12 December 2020

Myositis-specific and myositis-associated antibodies in overlap myositis in comparison to primary dermatopolymyositis: Relevance for clinical classification: retrospective study of 169 patients

1 reference

12 December 2020

Overlap connective tissue disease syndromes

1 reference

12 December 2020

Clinical and serological characteristics of 125 Dutch myositis patients. Myositis specific autoantibodies aid in the differential diagnosis of the idiopathic inflammatory myopathies

1 reference

12 December 2020

Comment on: Clinical utility of anti-signal recognition particle antibody in the differential diagnosis of myopathies

1 reference

12 December 2020

Subclinical myopathy in patients affected with newly diagnosed colorectal cancer at clinical onset of disease: evidence from skeletal muscle biopsies

1 reference

12 December 2020

Myositis autoantibodies in Korean patients with inflammatory myositis: anti-140-kDa polypeptide antibody is primarily associated with rapidly progressive interstitial lung disease independent of clinically amyopathic dermatomyositis

1 reference

12 December 2020

Clinical and serologic characterization of an Argentine pediatric myositis cohort: identification of a novel autoantibody (anti-MJ) to a 142-kDa protein

1 reference

12 December 2020

Clinical manifestations of dermatomyositis and clinically amyopathic dermatomyositis patients with positive expression of anti-melanoma differentiation-associated gene 5 antibody

1 reference

12 December 2020

Anti-Ku antibodies in connective tissue diseases: clinical and serological evaluation of 14 patients

1 reference

12 December 2020

Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy

1 reference

12 December 2020

Clinical features of anti-TIF1-α antibody-positive dermatomyositis patients are closely associated with coexistent dermatomyositis-specific autoantibodies and anti-TIF1-γ or anti-Mi-2 autoantibodies

1 reference

12 December 2020

Autoantibodies to small ubiquitin-like modifier activating enzymes in Japanese patients with dermatomyositis: comparison with a UK Caucasian cohort

1 reference

12 December 2020

Analysis of dermatomyositis-specific autoantibodies and clinical characteristics in Japanese patients

1 reference

12 December 2020

Anti-TIF1γ antibodies (anti-p155) in adult patients with dermatomyositis: comparison of different diagnostic assays

1 reference

12 December 2020

Autoantibodies and their significance in myositis

1 reference

12 December 2020

Characterization of dermatomyositis with coexistence of anti-Jo-1 and anti-SRP antibodies

1 reference

12 December 2020

Clinical and histopathological features of myopathies in Japanese patients with anti-SRP autoantibodies.

1 reference

12 December 2020

The type I interferon system in idiopathic inflammatory myopathies

1 reference

12 December 2020

Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes

1 reference

12 December 2020

High specificity of myositis specific autoantibodies for myositis compared with other neuromuscular disorders

1 reference

12 December 2020

Expression of myositis specific autoantigens during post-natal myogenesis

1 reference

12 December 2020

Anti-MDA5 and anti-TIF1-gamma antibodies have clinical significance for patients with dermatomyositis

1 reference

12 December 2020

Activation of the endoplasmic reticulum stress response in autoimmune myositis: Potential role in muscle fiber damage and dysfunction

1 reference

12 December 2020

Clinical features and outcome in a Danish cohort of juvenile dermatomyositis patients.

1 reference

12 December 2020

A possible mechanism for endogenous activation of the type I interferon system in myositis patients with anti-Jo-1 or anti-Ro 52/anti-Ro 60 autoantibodies

1 reference

12 December 2020

10.1007/S11926-013-0335-1

Identifiers

DOI

1 reference

Dimensions Publication ID

28 August 2017

1045689715

0 references

Fatcat ID

release_juhmiojjyvdzppw77o5ape4ayy

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/juhmiojjyvdzppw77o5ape4ayy

24 November 2022

mapped directly with Wikidata item

1 reference